InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+28.2%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the full record of transactions filed by Manion Douglas J., Directeur Exécutif. Insider active across 2 companies, notably Arena Pharmaceuticals INC. In total, 7 filings have been logged. Split: 2 buys · 0 sell. Total volume traded: €94k. History available since 15 August 2021. The latest transaction was disclosed on 17 March 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Manion Douglas J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
27,000 股Common StockSEC:0001209191-24-000416:0
15,575 股Common StockSEC:0001209191-23-044445:0
6,300 股@ US$7.862349.5% 占其流量Common StockSEC:0001209191-23-019743:0
标准退出：2023年6月15日 (T+90)
6,500 股@ US$7.73550.5% 占其流量Common StockSEC:0001209191-23-017626:0
标准退出：2023年6月7日 (T+90)
15,000 股Common StockSEC:0001628280-22-005892:0
21,462 股0Common StockSEC:0001628280-22-000342:0
15,000 股0Common StockSEC:0001628280-21-017169:0
7 条申报中的 7 条
About Manion Douglas J.
Douglas J. Manion is the EVP of Research & Development at Arena Pharmaceuticals Inc. He oversees the company's research and development initiatives aimed at innovating in the pharmaceutical field. With deep expertise, Douglas plays a crucial role in the strategy for developing new treatments and products.
